Search hospitals > Maryland > Bethesda
National Cancer Institute (NCI)
Claim this profileBethesda, Maryland 20814
Global Leader in Cancer
Global Leader in Pancreatic Cancer
Conducts research for Breast Cancer
Conducts research for Melanoma
Conducts research for Tumors
296 reported clinical trials
11 medical researchers
Summary
National Cancer Institute (NCI) is a medical facility located in Bethesda, Maryland. This center is recognized for care of Cancer, Pancreatic Cancer, Breast Cancer, Melanoma, Tumors and other specialties. National Cancer Institute (NCI) is involved with conducting 296 clinical trials across 394 conditions. There are 11 research doctors associated with this hospital, such as A P. Chen, Nirali N. Shah, John Glod, MD, and Deborah Citrin, MD.Area of expertise
1Cancer
Global LeaderStage IV
EWSR1/ATF1 positive
EWSR1/CREB1 positive
2Pancreatic Cancer
Global LeaderStage IV
BRCA positive
Top PIs
A P. ChenNational Institutes of Health Clinical Center3 years of reported clinical research
Expert in Cancer
Expert in Pancreatic Cancer
25 reported clinical trials
68 drugs studied
Nirali N. ShahNational Institutes of Health, Clinical Center8 years of reported clinical research
Studies Acute Myeloid Leukemia
Studies Leukemia
12 reported clinical trials
16 drugs studied
John Glod, MDNational Cancer Institute Pediatric Oncology Branch9 years of reported clinical research
Studies Brain Tumor
Studies Low Grade Glioma
10 reported clinical trials
13 drugs studied
Deborah Citrin, MDNational Cancer Institute3 years of reported clinical research
Studies Prostate Cancer
Studies Endometrial Cancer
6 reported clinical trials
10 drugs studied
Clinical Trials running at National Cancer Institute (NCI)
Cancer
Skin Cancer
Melanoma
Bladder Cancer
Small Cell Lung Cancer
Kidney Cancer
Hairy Cell Leukemia
Peripheral Nerve Sheath Tumor
Lung Cancer
Solid Tumors
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
ANK-101
for Cancer
This is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of tolododekin alfa (ANK-101) in participants with advanced solid tumors who have progressed during or after receiving standard of care (SOC) therapy or who will not benefit from such therapy. The study will be conducted in three parts; in Part 1, participants with superficial lesions will receive ANK-101 as a single agent; in Part 2, participants with visceral lesions will receive ANK-101 as a single agent; and in Part 3, participants with cutaneous squamous cell carcinoma (CSCC) will receive ANK-101 in combination with cemiplimab.
Recruiting1 award Phase 1
Olaparib
for Bladder Cancer
This trial studies how well olaparib works in patients with advanced bladder and other genitourinary cancers that have DNA-repair defects. Olaparib is a drug that stops cancer cells from fixing their damaged DNA, which can help to stop the cancer from growing. The trial targets patients whose cancers have spread and are not responsive to standard treatments.
Recruiting1 award Phase 220 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at National Cancer Institute (NCI)?
National Cancer Institute (NCI) is a medical facility located in Bethesda, Maryland. This center is recognized for care of Cancer, Pancreatic Cancer, Breast Cancer, Melanoma, Tumors and other specialties. National Cancer Institute (NCI) is involved with conducting 296 clinical trials across 394 conditions. There are 11 research doctors associated with this hospital, such as A P. Chen, Nirali N. Shah, John Glod, MD, and Deborah Citrin, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.